Pulse Biosciences’ CellFX nsPFA 360 cardiac catheter, which is still in the investigational stage, is uniquely designed to produce a nonthermal ablation, initially targeted for pulmonary vein ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated Oxygen (SSO 2 ...

The company will launch its catheter system (2Fr Coronary XO Cross 014 Microcath) for use with 0.014-in. guidewires in 90 cm, 135 cm, 150 cm and 175 cm lengths.

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Cook Medical announced its hydrophilic selective catheter is available again for use in the U.S. and Canada.The catheter (Slip-Cath) previously received FDA approval in 2012 but was taken off the ...

Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and ...

A device known as the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in ...